Long-term safety and tolerability of TAK-881 in subjects with Primary Immunodeficiency Diseases
Clinical Trial Grant
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Takeda Development Center Americas, Inc
Start Date
June 13, 2024
End Date
December 1, 2027
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Takeda Development Center Americas, Inc
Start Date
June 13, 2024
End Date
December 1, 2027